Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Aristo Bio-Tech and Lifescience Financial Results

Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.

Source

NSE filing, NSE: ARISTO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aristo Bio-Tech and Lifescience Ltd: key numbers

Share price
₹86.00
Market cap
₹58.55 Cr
Revenue (annual)
₹363.7 Cr
Net profit (annual)
₹7.18 Cr
P/E (TTM)
8.2×Sector 34.1×
Promoter holding
73.42%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aristo Bio-Tech and Lifescience Ltd

All →

Other financial results announcements

All →